Results for tag: "Pharyngeal Cancer Drug"

Pharyngeal cancer is a type of cancer that affects the pharynx, which is the hollow tube that connects the nose and mouth to the esophagus. Treatment for pharyngeal cancer typically involves a combination of surgery, radiation therapy, and chemotherapy. Oncology drugs are used to treat cancer, and they can be used alone or in combination with other treatments. The pharyngeal cancer drug market is a subset of the larger oncology drug market. It includes drugs that are used to treat pharyngeal cancer, such as chemotherapy drugs, targeted therapies, and immunotherapies. These drugs are used to reduce the size of tumors, reduce the risk of recurrence, and improve the quality of life for patients. Some companies in the pharyngeal cancer drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies develop and market drugs for the treatment of pharyngeal cancer. Show Less Read more